HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ajda Coker-Gürkan Selected Research

Sirolimus (Rapamycin)

10/2016mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ajda Coker-Gürkan Research Topics

Disease

2Neoplasms (Cancer)
10/2016 - 06/2015
1Prostatic Neoplasms (Prostate Cancer)
10/2016
1Colonic Neoplasms (Colon Cancer)
06/2015
1Starvation
06/2015
1Disease Progression
01/2014
1Urolithiasis
01/2014

Drug/Important Bio-Agent (IBA)

2Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2016 - 06/2015
1Androgen Receptors (Androgen Receptor)IBA
10/2016
1AndrogensIBA
10/2016
1Sirolimus (Rapamycin)FDA Link
10/2016
1RoscovitineIBA
10/2016
16- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA
06/2015
1Glucose (Dextrose)FDA LinkGeneric
06/2015
1Proteins (Proteins, Gene)FDA Link
06/2015
1Urea (Carbamide)FDA LinkGeneric
01/2014
1Genetic Markers (Genetic Marker)IBA
01/2014